Cite

HARVARD Citation

    Halder, S. et al. (n.d.). P071 Supporting extrapolation of indications for ABP 501, the first adalimumab biosimilar: focus on Crohn's disease. Journal of Crohn's and colitis. p. S121. [Online]. 
  
Back to record